A detailed history of Resources Management Corp transactions in Novartis Ag stock. As of the latest transaction made, Resources Management Corp holds 250 shares of NVS stock, worth $26,070. This represents 0.0% of its overall portfolio holdings.

Number of Shares
250
Previous 250 -0.0%
Holding current value
$26,070
Previous $27,000 7.41%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$95.27 - $108.47 $14,290 - $16,270
-150 Reduced 37.5%
250 $24,000
Q4 2023

Feb 14, 2024

BUY
$92.27 - $101.54 $27,588 - $30,360
299 Added 296.04%
400 $40,000
Q4 2023

Feb 14, 2024

SELL
$92.27 - $101.54 $27,588 - $30,360
-299 Reduced 74.75%
101 $40,000
Q2 2023

Aug 16, 2023

BUY
$92.52 - $104.91 $24,425 - $27,696
264 Added 194.12%
400 $40,000
Q1 2023

May 11, 2023

SELL
$80.03 - $92.81 $21,127 - $24,501
-264 Reduced 66.0%
136 $5,000
Q4 2022

Feb 08, 2023

SELL
$75.55 - $92.52 $3,777 - $4,626
-50 Reduced 11.11%
400 $36,000
Q1 2022

May 20, 2022

SELL
$80.11 - $90.62 $41,657 - $47,122
-520 Reduced 53.61%
450 $39,000
Q3 2021

Nov 12, 2021

SELL
$81.78 - $95.14 $2,044 - $2,378
-25 Reduced 2.51%
970 $79,000
Q2 2021

Aug 10, 2021

SELL
$85.24 - $94.15 $16,195 - $17,888
-190 Reduced 16.03%
995 $91,000
Q3 2020

Nov 12, 2020

SELL
$82.14 - $91.0 $30,802 - $34,125
-375 Reduced 24.04%
1,185 $103,000
Q1 2020

May 04, 2020

SELL
$70.67 - $99.01 $1,060 - $1,485
-15 Reduced 0.95%
1,560 $129,000
Q3 2019

Dec 04, 2019

SELL
$85.54 - $94.26 $1,710 - $1,885
-20 Reduced 1.25%
1,575 $137,000
Q4 2018

Feb 21, 2019

SELL
$73.66 - $82.02 $4,051 - $4,511
-55 Reduced 3.33%
1,595 $136,000
Q3 2018

Nov 15, 2018

BUY
$66.94 - $77.43 $110,451 - $127,759
1,650 New
1,650 $142,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $224B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Resources Management Corp Portfolio

Follow Resources Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Resources Management Corp , based on Form 13F filings with the SEC.

News

Stay updated on Resources Management Corp with notifications on news.